Bonus & Incentive Agreements in the Biotechnology Industry
4,693 Contracts & Agreements
- 4D Molecular Therapeutics Inc (8 contracts)
- 89bio, Inc. (1)
- AbbVie Inc. (16)
- ABEONA THERAPEUTICS INC. (3)
- ACADIA PHARMACEUTICALS INC (9)
- ACCELERON PHARMA INC (21)
- Accustem Sciences Inc. (1)
- Achaogen, Inc. (14)
- ACHIEVE LIFE SCIENCES, INC. (8)
- Acorda Therapeutics (6)
- Actinium Pharmaceuticals, Inc. (3)
- Acumen Pharmaceuticals, Inc. (2)
- Acurx Pharmaceuticals, LLC (1)
- Adagio Therapeutics, Inc. (5)
- Adamas Pharmaceuticals Inc (8)
- Adhera Therapeutics, Inc. (9)
- ADiTx Therapeutics, Inc. (2)
- ADMA BIOLOGICS, INC. (1)
- ADURO BIOTECH, INC. (12)
- Advaxis, Inc. (1)
- Adverum Biotechnologies, Inc. (13)
- Aeglea BioTherapeutics, Inc. (12)
- Aerovate Therapeutics, Inc. (3)
- AGENUS INC (19)
- AgeX Therapeutics, Inc. (1)
- AGIOS PHARMACEUTICALS INC (14)
- AILERON THERAPEUTICS INC (11)
- Aimmune Therapeutics, Inc. (4)
- AKCEA THERAPEUTICS, INC. (6)
- Akebia Therapeutics, Inc. (23)
- Akero Therapeutics, Inc. (1)
- ALBIREO PHARMA, INC. (15)
- Aldeyra Therapeutics, Inc. (9)
- Alector, Inc. (5)
- Alexion Pharmaceuticals (25)
- Aligos Therapeutics, Inc. (8)
- Alkermes plc. (44)
- Allakos Inc. (3)
- Allarity Therapeutics, Inc. (1)
- Allena Pharmaceuticals, Inc. (3)
- Alliqua BioMedical, Inc. (12)
- Allogene Therapeutics, Inc. (2)
- Allovir, Inc. (2)
- ALNYLAM PHARMACEUTICALS, INC. (39)
- Alpha Healthcare Acquisition Corp. (10)
- ALPINE IMMUNE SCIENCES, INC. (8)
- Altimmune, Inc. (11)
- ALX ONCOLOGY HOLDINGS INC (2)
- AMARILLO BIOSCIENCES INC (3)
- AMARIN CORP PLC (15)
- AMERICAN CRYOSTEM Corp (2)
- Amgen Inc. (74)
- AMICUS THERAPEUTICS, INC. (22)
- AmpliPhi Biosciences Corp (3)
- Amplitude Healthcare Acquisition Corp (5)
- ANAPTYSBIO INC (3)
- Anika Therapeutics (18)
- Anixa Biosciences Inc (4)
- Annexon, Inc. (9)
- Annovis Bio, Inc. (3)
- Apellis Pharmaceuticals, Inc. (9)
- APPLIED GENETIC TECHNOLOGIES CORP (9)
- Applied Molecular Transport Inc. (7)
- Applied Therapeutics Inc. (6)
- Aprea Therapeutics, Inc. (2)
- Aptevo Therapeutics Inc. (4)
- AquaBounty Technologies, Inc. (4)
- AQUINOX PHARMACEUTICALS, INC (6)
- Aravive, Inc. (4)
- Arbutus Biopharma Corp (6)
- ARCA biopharma, Inc. (23)
- Arcellx, Inc. (3)
- Arcturus Therapeutics Holdings Inc. (1)
- Arcus Biosciences, Inc. (4)
- Arcutis Biotherapeutics, Inc. (4)
- ARDELYX, INC. (7)
- ARENA PHARMACEUTICALS INC (50)
- ARROWHEAD PHARMACEUTICALS, INC. (6)
- Arsanis, Inc. (26)
- Artiva Biotherapeutics, Inc. (4)
- ARYA Sciences Acquisition Corp II (4)
- ASSEMBLY BIOSCIENCES, INC. (18)
- Atara Biotherapeutics, Inc. (10)
- Athenex, Inc. (4)
- ATHERSYS, INC (25)
- ATOSSA GENETICS INC (10)
- Atreca, Inc. (3)
- aTYR PHARMA INC (7)
- Aura Biosciences, Inc. (3)
- Aurinia Pharmaceuticals Inc. (1)
- AVEO PHARMACEUTICALS INC (10)
- Avid Bioservices, Inc. (17)
- Avidity Biosciences, Inc. (5)
- Avita Therapeutics, Inc. (1)
- AVROBIO, Inc. (6)
- Axcella Health Inc. (4)
- Axovant Sciences Ltd. (7)
- Ayala Pharmaceuticals, Inc. (1)
- AZIYO BIOLOGICS, INC. (4)
- AzurRx BioPharma, Inc. (2)
- BCTG Acquisition Corp. (3)
- Beam Therapeutics Inc. (8)
- BeiGene, Ltd. (43)
- BELLICUM PHARMACEUTICALS, INC (20)
- Benitec Biopharma Inc. (3)
- BICYCLE THERAPEUTICS Ltd (3)
- BIO-PATH HOLDINGS INC (19)
- bioAffinity Technologies, Inc. (3)
- BioAtla, Inc. (2)
- BioCardia, Inc. (6)
- BIOCEPT INC (7)
- BIOCRYST PHARMACEUTICALS INC (17)
- Biogen Inc. (16)
- Biohaven Pharmaceutical Holding Co Ltd. (5)
- BioLife4D Corp (1)
- BIOMARIN PHARMACEUTICAL INC (13)
- Biomea Fusion, Inc. (6)
- BioRestorative Therapies, Inc. (5)
- BIOSPECIFICS TECHNOLOGIES CORP (1)
- Biostage, Inc. (8)
- BIOTIME INC (6)
- BioXcel Therapeutics, Inc. (8)
- Black Diamond Therapeutics, Inc. (3)
- Blue Water Vaccines Inc. (12)
- bluebird bio, Inc. (2)
- Blueprint Medicines Corp (13)
- Bolt Biotherapeutics, Inc. (6)
- Bone Biologics Corp (3)
- BRAINSTORM CELL THERAPEUTICS INC. (5)
- BridgeBio Pharma, Inc. (7)
- C4 Therapeutics, Inc. (3)
- Cabaletta Bio, Inc. (1)
- CALADRIUS BIOSCIENCES, INC. (2)
- Calithera Biosciences, Inc. (6)
- Calyxt, Inc. (19)
- CANCER GENETICS, INC (7)
- Candel Therapeutics, Inc. (2)
- CAPRICOR THERAPEUTICS, INC. (5)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
- Capstone Therapeutics Corp. (8)
- CareDx, Inc. (11)
- Caribou Biosciences, Inc. (11)
- CASI Pharmaceuticals, Inc. (13)
- CASTLE BIOSCIENCES INC (7)
- Castle Creek Biosciences, Inc. (2)
- CATABASIS PHARMACEUTICALS INC (9)
- CATALYST BIOSCIENCES, INC. (30)
- CATALYST PHARMACEUTICALS, INC. (2)
- Celcuity Inc. (9)
- Cell Source, Inc. (3)
- Celldex Therapeutics, Inc. (13)
- Cellectar Biosciences, Inc. (17)
- Cellular Biomedicine Group, Inc. (2)
- Celsion CORP (11)
- Centessa Pharmaceuticals Ltd (1)
- Century Therapeutics, Inc. (2)
- Chanticleer Holdings, Inc. (2)
- Chardan Healthcare Acquisition 2 Corp. (3)
- Chardan Healthcare Acquisition Corp. (1)
- Checkpoint Therapeutics, Inc. (3)
- Chelsea Worldwide Inc. (1)
- ChemoCentryx, Inc. (8)
- CHIMERIX INC (8)
- Cibus Global, Ltd. (1)
- Cidara Therapeutics, Inc. (7)
- CLEVELAND BIOLABS INC (5)
- Clovis Oncology, Inc. (4)
- CM Life Sciences III Inc. (3)
- Codiak BioSciences, Inc. (3)
- CohBar, Inc. (5)
- Coherus BioSciences, Inc. (10)
- Comera Life Sciences Holdings, Inc. (2)
- COMPASS Pathways plc (2)
- Conatus Pharmaceuticals Inc. (10)
- CONCERT PHARMACEUTICALS, INC. (6)
- Consonance-HFW Acquisition Corp. (2)
- Constellation Alpha Capital Corp. (7)
- CONSTELLATION PHARMACEUTICALS INC (5)
- CONTRAFECT Corp (6)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- Cortexyme, Inc. (2)
- Corvus Pharmaceuticals, Inc. (1)
- Crinetics Pharmaceuticals, Inc. (9)
- CRISPR Therapeutics AG (16)
- CTD HOLDINGS INC (1)
- CTI BIOPHARMA CORP (32)
- Cue Biopharma, Inc. (7)
- Cullinan Oncology, LLC (2)
- Curative Biotechnology Inc (8)
- CURIS INC (9)
- Cyclacel Pharmaceuticals, Inc. (9)
- Cyclerion Therapeutics, Inc. (2)
- CytoDyn Inc. (11)
- Cytokinetics, Incorporated (11)
- CytomX Therapeutics, Inc. (9)
- CYTORI THERAPEUTICS, INC. (11)
- CYTRX CORP (13)
- Day One Biopharmaceuticals Holding Co LLC (2)
- Decibel Therapeutics, Inc. (10)
- DECIPHER BIOSCIENCES, INC. (2)
- Deciphera Pharmaceuticals, Inc. (11)
- DelMar Pharmaceuticals, Inc. (7)
- Denali Therapeutics Inc. (2)
- Dermavant Sciences Ltd (3)
- Dermira, Inc. (4)
- Design Therapeutics, Inc. (3)
- DiaMedica Therapeutics Inc. (9)
- Dicerna Pharmaceuticals Inc (9)
- Diffusion Pharmaceuticals Inc. (5)
- DYADIC INTERNATIONAL INC (4)
- Dynamics Special Purpose Corp. (2)
- DYNAVAX TECHNOLOGIES CORP (8)
- Dyne Therapeutics, Inc. (10)
- Eagle Pharmaceuticals, Inc. (9)
- Edge Therapeutics, Inc. (9)
- Editas Medicine, Inc. (6)
- Eidos Therapeutics, Inc. (8)
- Eiger BioPharmaceuticals, Inc. (11)
- Elevation Oncology, Inc. (2)
- Eliem Therapeutics, Inc. (5)
- Emerald Bioscience, Inc. (9)
- Emergent BioSolutions Inc. (4)
- Enanta Pharmaceuticals, Inc. (22)
- Enochian Biosciences Inc (4)
- Entasis Therapeutics Holdings Inc. (13)
- Entrada Therapeutics, Inc. (3)
- Environmental Impact Acquisition Corp (1)
- ENZON PHARMACEUTICALS, INC. (4)
- Epizyme, Inc. (13)
- Equillium, Inc. (3)
- Erasca, Inc. (2)
- Esperion Therapeutics, Inc. (5)
- Evelo Biosciences, Inc. (4)
- EVOLUTIONARY GENOMICS, INC. (1)
- EXACT SCIENCES CORP (19)
- Exelixis (31)
- EXICURE, INC. (2)
- FATE THERAPEUTICS INC (9)
- FENNEC PHARMACEUTICALS INC. (1)
- Fibrocell Science, Inc. (9)
- FIBROGEN INC (4)
- Finch Therapeutics Group, Inc. (5)
- FIVE PRIME THERAPEUTICS INC (13)
- Flex Pharma, Inc. (4)
- Flexion Therapeutics Inc (3)
- FLUOROPHARMA MEDICAL, INC. (1)
- Foghorn Therapeutics Inc. (9)
- Forma Therapeutics Holdings, Inc., (3)
- Fortress Biotech, Inc. (5)
- Forty Seven, Inc. (6)
- Frequency Therapeutics, Inc. (7)
- FS Development Corp. (2)
- FS Development Corp. II (3)
- Fusion Pharmaceuticals Inc. (3)
- G1 Therapeutics, Inc. (8)
- Gain Therapeutics, Inc. (2)
- GALECTIN THERAPEUTICS INC (4)
- Galecto Inc. (5)
- Galera Therapeutics, Inc. (5)
- Gamida Cell Ltd. (6)
- Gemphire Therapeutics Inc. (10)
- Gene Biotherapeutics, Inc. (1)
- GENELUX CORP (7)
- Generation Bio Co. (7)
- GENEREX BIOTECHNOLOGY CORP (1)
- GENOCEA BIOSCIENCES, INC. (14)
- Genprex, Inc. (3)
- GeoVax Labs, Inc. (6)
- GERON CORP (25)
- Gilead Sciences (72)
- Global Blood Therapeutics, Inc. (6)
- GLYCOMIMETICS INC (10)
- Gossamer Bio, Inc. (7)
- Grail, Inc. (3)
- Graphite Bio, Inc. (4)
- Greenwich LifeSciences, Inc. (1)
- Gritstone Oncology, Inc. (8)
- GT Biopharma, Inc. (1)
- GTX INC (19)
- GX Acquisition Corp. (4)
- HALOZYME THERAPEUTICS INC (2)
- Harpoon Therapeutics, Inc. (4)
- HCW Biologics Inc. (4)
- Health Sciences Acquisitions Corp (3)
- HEAT BIOLOGICS, INC. (13)
- HEMISPHERX BIOPHARMA INC (3)
- HERON THERAPEUTICS, INC. (4)
- HilleVax, Inc. (2)
- Hillstream BioPharma Inc. (2)
- HISTOGENICS CORP (10)
- Homology Medicines, Inc. (7)
- HOOKIPA Pharma Inc. (9)
- HUMANIGEN, INC (9)
- iBio, Inc. (4)
- Icosavax, Inc. (3)
- IDEAYA Biosciences, Inc. (8)
- IDERA PHARMACEUTICALS, INC. (25)
- IGM Biosciences, Inc. (6)
- Imago BioSciences, Inc. (7)
- Immix Biopharma, Inc. (2)
- IMMUCELL CORP (16)
- IMMUNE PHARMACEUTICALS INC (2)
- Immuneering Corp (3)
- ImmunoCellular Therapeutics, Ltd. (8)
- IMMUNOGEN INC (34)
- Immunome Inc. (6)
- IMMUNOMEDICS INC (13)
- IMPEL NEUROPHARMA INC (4)
- IN8BIO, INC. (8)
- Incyte (25)
- INFINITY PHARMACEUTICALS, INC. (13)
- Inhibikase Therapeutics, Inc. (5)
- Inhibrx, Inc. (10)
- Inmune Bio, Inc. (5)
- Innovation Pharmaceuticals Inc. (4)
- INOVIO PHARMACEUTICALS, INC. (13)
- Inozyme Pharma, Inc. (6)
- INSMED Inc (42)
- Inspyr Therapeutics, Inc. (1)
- Instil Bio, Inc. (6)
- Intec Parent Inc. (2)
- Intec Pharma Ltd. (1)
- Intellia Therapeutics, Inc. (5)
- INTERCEPT PHARMACEUTICALS, INC. (17)
- INTREXON CORP (22)
- Intrinsic Medicine, Inc. (2)
- Invitae Corp (29)
- IONIS PHARMACEUTICALS INC (6)
- IOVANCE BIOTHERAPEUTICS, INC. (16)
- IRONWOOD PHARMACEUTICALS INC (19)
- Isoray, Inc. (2)
- iTeos Therapeutics, Inc. (2)
- Janux Therapeutics, Inc. (3)
- Jounce Therapeutics, Inc. (4)
- Kadmon Holdings, Inc. (7)
- KalVista Pharmaceuticals, Inc. (3)
- Karuna Therapeutics, Inc. (10)
- Karyopharm Therapeutics Inc. (21)
- KBL MERGER CORP. IV (7)
- Keros Therapeutics, Inc. (6)
- Kezar Life Sciences, Inc. (7)
- Kindred Biosciences, Inc. (8)
- Kiniksa Pharmaceuticals, Ltd. (12)
- Kinnate Biopharma Inc. (3)
- Kiromic Biopharma, Inc. (1)
- Kodiak Sciences Inc. (7)
- Kronos Bio, Inc. (1)
- Krystal Biotech, Inc. (8)
- Kura Oncology, Inc. (6)
- Kymera Therapeutics, Inc. (2)
- LA JOLLA PHARMACEUTICAL CO (4)
- Lantern Pharma Inc. (2)
- LEAP THERAPEUTICS, INC. (3)
- Leisure Acquisition Corp. (4)
- LEXICON PHARMACEUTICALS, INC. (22)
- LianBio (5)
- LifeSci Acquisition Corp. (4)
- Ligand Pharmaceuticals Incorporated (3)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
- Locust Walk Acquisition Corp. (5)
- LogicBio Therapeutics, Inc. (7)
- LONGEVERON LLC (2)
- Lyell Immunopharma, Inc. (5)
- MACROGENICS INC (11)
- MADRIGAL PHARMACEUTICALS, INC. (1)
- Magenta Therapeutics, Inc. (4)
- MAIA Biotechnology, Inc. (10)
- MANNKIND CORP (5)
- MARIZYME INC (9)
- Marker Therapeutics, Inc. (4)
- MATEON THERAPEUTICS INC (6)
- Matinas BioPharma Holdings, Inc. (1)
- MAXCYTE, INC. (10)
- MEDICINOVA INC (6)
- Medovex Corp. (1)
- MeiraGTx Holdings plc (8)
- MERRIMACK PHARMACEUTICALS INC (2)
- Mersana Therapeutics, Inc. (8)
- Metacrine, Inc. (4)
- Millendo Therapeutics, Inc. (24)
- MiMedx Group, Inc. (37)
- Minerva Neurosciences, Inc. (4)
- MiNK Therapeutics, Inc. (10)
- MIRAGEN THERAPEUTICS, INC. (24)
- Mirati Therapeutics, Inc. (4)
- Mirum Pharmaceuticals, Inc. (8)
- Moderna, Inc. (2)
- Molecular Templates, Inc. (8)
- Momenta Pharmaceuticals, Inc. (28)
- Monopar Therapeutics (6)
- Monte Rosa Therapeutics, Inc. (2)
- Morphic Holding, Inc. (4)
- MUSTANG BIO, INC. (2)
- Myovant Sciences Ltd. (11)
- Myriad Genetics, Inc. (18)
- NantKwest, Inc. (4)
- Natera, Inc. (3)
- NAVIDEA BIOPHARMACEUTICALS, INC. (7)
- NEUROCRINE BIOSCIENCES INC (9)
- NEUROTROPE BIOSCIENCE, INC. (7)
- Neurotrope, Inc. (5)
- NEWLINK GENETICS CORP (14)
- NexImmune, Inc. (6)
- NextCure, Inc. (7)
- Nkarta, Inc. (3)
- NOVAVAX INC (13)
- Novus Therapeutics, Inc. (13)
- NTN BUZZTIME INC (27)
- Nuo Therapeutics, Inc. (5)
- Nurix Therapeutics, Inc. (2)
- Nuvalent, Inc. (4)
- Nuvectis Pharma, Inc. (1)
- Ohr Pharmaceutical Inc (7)
- Olema Pharmaceuticals, Inc. (4)
- Olivia Ventures, Inc. (2)
- Omega Therapeutics, Inc. (2)
- OncoCyte Corp (1)
- Oncorus, Inc. (6)
- ONCOSEC MEDICAL Inc (2)
- OPGEN INC (7)
- Ophthotech Corp. (13)
- Opko Health, Inc. (2)
- ORAGENICS INC (11)
- Orchard Therapeutics plc (2)
- Organicell Regenerative Medicine, Inc. (2)
- Organogenesis Holdings Inc. (2)
- ORGANOVO HOLDINGS, INC. (17)
- Oric Pharmaceuticals, Inc. (4)
- Outlook Therapeutics, Inc. (4)
- Ovid Therapeutics Inc. (10)
- Oyster Point Pharma, Inc. (5)
- PALATIN TECHNOLOGIES INC (11)
- Pasithea Therapeutics Corp. (2)
- Passage BIO, Inc. (2)
- PDL BIOPHARMA, INC. (24)
- PepGen Inc. (2)
- Pfenex Inc. (7)
- PharmaCyte Biotech, Inc. (1)
- PhaseBio Pharmaceuticals Inc (5)
- Phio Pharmaceuticals Corp. (8)
- PIERIS PHARMACEUTICALS, INC. (10)
- PMV Pharmaceuticals, Inc. (5)
- POLARITYTE, INC. (22)
- PORTOLA PHARMACEUTICALS INC (11)
- Poseida Therapeutics, Inc. (5)
- Praxis Precision Medicines, Inc. (9)
- PRECISION BIOSCIENCES INC (4)
- Prelude Therapeutics Inc (2)
- Prevail Therapeutics Inc. (2)
- Principia Biopharma Inc. (4)
- Progenics Pharmaceuticals, Inc. (8)
- PROGENITY, INC. (7)
- Prometheus Biosciences, Inc. (3)
- ProMIS Neurosciences Inc. (1)
- Propanc Biopharma, Inc. (1)
- Protagenic Therapeutics, Inc. (3)
- Protagonist Therapeutics, Inc (2)
- Protalix BioTherapeutics, Inc. (4)
- PROTEON THERAPEUTICS INC (7)
- PROTEOSTASIS THERAPEUTICS, INC. (6)
- Prothena Corp plc (24)
- ProtoKinetix, Inc. (5)
- PTC THERAPEUTICS, INC. (18)
- PUMA BIOTECHNOLOGY, INC. (10)
- Pyxis Oncology, Inc. (2)
- Q BioMed Inc. (1)
- Radius Health, Inc. (16)
- Rallybio Corp (7)
- RAPT Therapeutics, Inc. (3)
- Rasna Therapeutics Inc. (1)
- RECURSION PHARMACEUTICALS, INC. (3)
- Regeneron Pharmaceuticals (38)
- REGENERX BIOPHARMACEUTICALS INC (4)
- REGENXBIO Inc. (6)
- Regulus Therapeutics Inc. (6)
- Relay Therapeutics, Inc. (2)
- Reneo Pharmaceuticals, Inc. (8)
- RenovaCare, Inc. (4)
- RenovoRx, Inc. (6)
- Repare Therapeutics Inc. (3)
- Replimune Group, Inc. (1)
- Retrophin, Inc. (8)
- Revolution Medicines, Inc. (6)
- REXAHN PHARMACEUTICALS, INC. (6)
- Rezolute, Inc. (1)
- RHYTHM PHARMACEUTICALS, INC. (3)
- RIGEL PHARMACEUTICALS INC (34)
- RITTER PHARMACEUTICALS INC (8)
- ROCKET PHARMACEUTICALS, INC. (9)
- Rubius Therapeutics, Inc. (3)
- Sage Therapeutics, Inc. (3)
- Sana Biotechnology, Inc. (12)
- SANGAMO THERAPEUTICS, INC (9)
- SANGUI BIOTECH INTERNATIONAL INC (1)
- Sarepta Therapeutics, Inc. (31)
- Savara Inc (41)
- Scholar Rock Holding Corp (1)
- SEATTLE GENETICS INC (74)
- SELECTA BIOSCIENCES INC (3)
- SELLAS Life Sciences Group, Inc. (14)
- Sensei Biotherapeutics, Inc. (2)
- SERA PROGNOSTICS, INC. (4)
- Seres Therapeutics, Inc. (3)
- Sesen Bio, Inc. (14)
- Shattuck Labs, Inc. (3)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- Sierra Oncology, Inc. (3)
- Sigilon Therapeutics, Inc. (9)
- Silverback Therapeutics, Inc. (3)
- Social Capital Suvretta Holdings Corp. III (2)
- SOLENO THERAPEUTICS INC (7)
- Solid Biosciences Inc. (17)
- SOLIGENIX, INC. (7)
- Sorrento Therapeutics, Inc. (5)
- Spectrum Pharmaceuticals, Inc. (18)
- Spero Therapeutics, Inc. (16)
- SPHERIX INC (3)
- Spinning Eagle Acquisition Corp. (2)
- Spring Bank Pharmaceuticals, Inc. (14)
- SpringWorks Therapeutics, Inc. (3)
- SPRUCE BIOSCIENCES, INC. (6)
- SQZ Biotechnologies Co (4)
- Stellar Biotechnologies, Inc. (3)
- Stoke Therapeutics, Inc. (3)
- Sun BioPharma, Inc. (5)
- SUNESIS PHARMACEUTICALS INC (27)
- Surface Oncology, Inc. (8)
- SUTRO BIOPHARMA, INC. (3)
- Syndax Pharmaceuticals Inc (8)
- SYNLOGIC, INC. (14)
- Syros Pharmaceuticals, Inc. (8)
- T2 Biosystems, Inc. (4)
- Talaris Therapeutics, Inc. (7)
- Taysha Gene Therapies, Inc. (3)
- TCR2 THERAPEUTICS INC. (3)
- TENAX THERAPEUTICS, INC. (9)
- Tenaya Therapeutics, Inc. (4)
- TG THERAPEUTICS, INC. (2)
- Therapeutics Acquisition Corp. (9)
- Tocagen Inc (9)
- Tracon Pharmaceuticals, Inc. (7)
- Transcode Therapeutics, Inc. (2)
- Translate Bio, Inc. (10)
- TREVENA INC (7)
- TScan Therapeutics, Inc. (4)
- Turning Point Therapeutics, Inc. (3)
- Twist Bioscience Corp (2)
- TYME TECHNOLOGIES, INC. (3)
- Tyra Biosciences, Inc. (2)
- Ultragenyx Pharmaceutical Inc. (17)
- Unicycive Therapeutics, Inc. (2)
- uniQure N.V. (12)
- United Therapeutics Corp (21)
- Unity Biotechnology, Inc. (7)
- Unum Therapeutics Inc. (6)
- UroGen Pharma Ltd. (11)
- VACCINEX, INC. (3)
- Vaccitech plc (1)
- Vanda Pharmaceuticals Inc. (16)
- Vaxart, Inc. (10)
- Vaxcyte, Inc. (5)
- Vaxxinity, Inc. (4)
- VBI Vaccines Inc (1)
- Vera Therapeutics, Inc. (5)
- VERACYTE, INC. (9)
- Verastem, Inc. (23)
- Vericel Corp (31)
- Vertex Pharmaceuticals Inc (1)
- Verve Therapeutics, Inc. (10)
- VICAL INC (14)
- Viela Bio, Inc. (2)
- Vigil Neuroscience, Inc. (3)
- Viking Therapeutics, Inc. (7)
- Vir Biotechnology, Inc. (7)
- Virios Therapeutics, LLC (2)
- VistaGen Therapeutics, Inc. (5)
- VITAL THERAPIES INC (8)
- VITRO DIAGNOSTICS INC (4)
- Vor Biopharma Inc. (2)
- Voyager Therapeutics, Inc. (1)
- vTv Therapeutics Inc. (3)
- Werewolf Therapeutics, Inc. (8)
- WINDTREE THERAPEUTICS INC (13)
- XBiotech Inc. (4)
- Xencor Inc (4)
- Xenetic Biosciences, Inc. (1)
- Xenon Pharmaceuticals Inc. (5)
- Xilio Therapeutics, Inc. (10)
- XOMA Corp (11)
- Y-mAbs Therapeutics, Inc. (9)
- YIELD10 BIOSCIENCE, INC. (10)
- ZAFGEN, INC. (5)
- Zai Lab Ltd (1)
- Zentalis Pharmaceuticals, LLC (5)
- ZIOPHARM ONCOLOGY INC (10)
- Zymeworks Inc. (1)
- 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Exercise Notice, RSU Award Grant Notice and RSU Award Agreement (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
- Form of Restricted Stock Unit Agreement Pursuant to the Dyadic International, Inc. 2021 Equity Incentive Plan (DYADIC INTERNATIONAL INC, Filed With SEC on March 28, 2024)
- Form of Stock Option Agreement Pursuant to the Dyadic International, Inc. 2021 Equity Incentive Plan (DYADIC INTERNATIONAL INC, Filed With SEC on March 28, 2024)
- Q32 Bio Inc. Senior Executive Cash Incentive Bonus Plan (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
- Q32 Bio Inc. 2024 Stock Option and Incentive Plan, and form of award agreements thereunder (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
- Q32 Bio Inc. 2017 Stock Incentive Plan, and form of award agreements thereunder (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
- 2017 Share Incentive Plan, as amended (Gamida Cell Ltd., Filed With SEC on March 27, 2024)
- Dyne Therapeutics Inc. 2024 Inducement Equity Incentive Plan (Dyne Therapeutics, Inc., Filed With SEC on March 25, 2024)
- Retention Bonus Agreement by and between Finch Therapeutics Group, Inc. and Marc Blaustein, dated as December 7, 2022 (Finch Therapeutics Group, Inc., Filed With SEC on March 25, 2024)
- 2024 Equity Incentive Plan and related form agreements (Graphite Bio, Inc., Filed With SEC on March 22, 2024)
- Form of Incentive Warrant included in Warrant Agreement dated March 19, 2024 (AgeX Therapeutics, Inc., Filed With SEC on March 22, 2024)
- Form of Stock Option Agreement for Executives under the Amended and Restated Dianthus Therapeutics, Inc. Stock Option and Incentive Plan (Magenta Therapeutics, Inc., Filed With SEC on March 21, 2024)
- Form of Restricted Stock Unit Agreement under the Registrants 2021 Equity Incentive Plan (SERA PROGNOSTICS, INC., Filed With SEC on March 20, 2024)
- Retention Bonus Agreement by and between Synlogic, Inc. and Mary Beth Dooley, dated as of March 7, 2024 (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
- Retention Bonus Agreement by and between Synlogic, Inc. and Antoine Awad, dated as of March 7, 2024 (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
- Form of Stock Option Grant Notice and Stock Option Agreement under 2023 Inducement Equity Incentive Award Plan (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
- 2023 Inducement Equity Incentive Award Plan (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
- Amendment No. 1 to Leap Therapeutics, Inc. 2022 Equity Incentive Plan (LEAP THERAPEUTICS, INC., Filed With SEC on March 18, 2024)
- Amended and Restated 2021 Equity Incentive Plan, and forms of agreements thereunder (Tocagen Inc, Filed With SEC on March 18, 2024)
- Assembly Biosciences, Inc. 2024 Corporate Bonus Plan (ASSEMBLY BIOSCIENCES, INC., Filed With SEC on March 15, 2024)
- Amendment to Form of Restricted Stock Unit Grant Notice under the UroGen Pharma Ltd. 2017 Equity Incentive Plan (UroGen Pharma Ltd., Filed With SEC on March 14, 2024)
- Form of Officer Restricted Stock Unit Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy) (Akebia Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Form of Officer Stock Option Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy) (Akebia Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Form of Officer Cash Bonus Agreement (Reflecting Clawback Policy) (Akebia Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Restricted Stock Award Agreement for Company Employees under the Larimar Therapeutics, Inc. 2020 Equity Incentive Plan (ZAFGEN, INC., Filed With SEC on March 14, 2024)
- Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- Form of Restricted Stock Unit Agreement under the 2024 Inducement Stock Incentive Plan (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- Form of Non-Statutory Stock Option Agreement under the 2024 Inducement Stock Incentive Plan (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- 2024 Inducement Stock Incentive Plan (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- 2019 Inducement Equity Incentive Plan, as amended (Spero Therapeutics, Inc., Filed With SEC on March 13, 2024)
- Form of Restricted Stock Unit Agreement under the 2020 Stock Incentive Plan (Inozyme Pharma, Inc., Filed With SEC on March 12, 2024)
- 2019 Equity Incentive Plan (As amended March 2024) (Enanta Pharmaceuticals, Inc., Filed With SEC on March 12, 2024)
- Janux Therapeutics, Inc. Incentive Compensation Recoupment Policy (Janux Therapeutics, Inc., Filed With SEC on March 8, 2024)
- 2020 Equity Incentive Plan, and forms of award agreements thereunder (Galecto Inc., Filed With SEC on March 8, 2024)
- Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan (Werewolf Therapeutics, Inc., Filed With SEC on March 7, 2024)
- 2021 Employment Inducement Incentive Award Plan of the Registrant, as amended (the Inducement Plan) (GTX INC, Filed With SEC on March 7, 2024)
- 2019 Incentive Award Plan of the Registrant (the 2019 Plan) (GTX INC, Filed With SEC on March 7, 2024)
- 2015 Equity Incentive Plan of Private Oncternal, as amended (the 2015 Plan) (GTX INC, Filed With SEC on March 7, 2024)
- Form of Director Restricted Stock Unit Award Grant Notice and Award Agreement under 2023 Equity Incentive Plan (MACROGENICS INC, Filed With SEC on March 7, 2024)
- Form of Director Stock Option Grant Notice and Stock Option Agreement under 2023 Equity Incentive Plan (MACROGENICS INC, Filed With SEC on March 7, 2024)